These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 30152450)

  • 21. Challenges in Implementing a Biorisk Management Program at Universitas Indonesia: A Checklist Tool for Biorisk Management.
    Naroeni A; Bachtiar EW; Ibrahim F; Bela B; Kusminanti Y; Pujiriani I; Lestari F
    Health Secur; 2016; 14(6):375-381. PubMed ID: 27830940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent.
    Kaufer AM; Theis T; Lau KA; Gray JL; Rawlinson WD
    Pathology; 2020 Dec; 52(7):790-795. PubMed ID: 33070960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biosafety Recommendations for Work with Influenza Viruses Containing a Hemagglutinin from the A/goose/Guangdong/1/96 Lineage.
    ; Gangadharan D; Smith J; Weyant R
    MMWR Recomm Rep; 2013 Jun; 62(RR-06):1-7. PubMed ID: 23803973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The changing world of biocontainment and biosecurity.
    Jeggo M
    Dev Biol (Basel); 2007; 128():47-51. PubMed ID: 18084927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of biosafety precautions in Khartoum state diagnostic laboratories, Sudan.
    Elduma AH
    Pan Afr Med J; 2012; 11():19. PubMed ID: 22514753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biocontainment laboratory risk assessment: perspectives and considerations.
    Patterson A; Fennington K; Bayha R; Wax D; Hirschberg R; Boyd N; Kurilla M
    Pathog Dis; 2014 Jul; 71(2):102-8. PubMed ID: 24591404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biosafety practices associated with potential agents of biocrime and biowarfare.
    Burnett LC
    Curr Protoc Microbiol; 2006 Dec; Chapter 1():Unit 1A.2. PubMed ID: 18770570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Issues in biosecurity and biosafety.
    Nordmann BD
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S66-9. PubMed ID: 20696555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017.
    Appelt S; Jacob D; Rohleder AM; Bråve A; Szekely Björndal Å; Di Caro A; Grunow R;
    Euro Surveill; 2020 Sep; 25(36):. PubMed ID: 32914748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International Society for Analytical Cytology biosafety standard for sorting of unfixed cells.
    Schmid I; Lambert C; Ambrozak D; Marti GE; Moss DM; Perfetto SP;
    Cytometry A; 2007 Jun; 71(6):414-37. PubMed ID: 17385740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic approach towards establishing a National Inventory of Dangerous Pathogens.
    Vennis IM; Bleijs DA; Brizee S; Van Den Berg HHJL; Kampert E; Rutjes SA; Van Passel MWJ
    Glob Health Action; 2021 Jan; 14(1):1971866. PubMed ID: 34493169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biosafety and Biosecurity in European Containment Level 3 Laboratories: Focus on French Recent Progress and Essential Requirements.
    Pastorino B; de Lamballerie X; Charrel R
    Front Public Health; 2017; 5():121. PubMed ID: 28620600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lessons to be Learned from Recent Biosafety Incidents in the United States.
    Weiss S; Yitzhaki S; Shapira SC
    Isr Med Assoc J; 2015 May; 17(5):269-73. PubMed ID: 26137650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. International health threats and global early warning and response mechanisms.
    Tekola B; Myers L; Lubroth J; Plee L; Calistri P; Pinto J
    Rev Sci Tech; 2017 Aug; 36(2):657-670. PubMed ID: 30152454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engaging scientists and veterinarians in strengthening biosecurity systems.
    Hueston WD
    Rev Sci Tech; 2017 Aug; 36(2):681-690. PubMed ID: 30152452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current problems arising from not having biosafety level 4 laboratories in Japan--qualitative study of infectious disease experts].
    Yamamoto Y; Horiguchi I; Marui E
    Nihon Eiseigaku Zasshi; 2009 Sep; 64(4):806-10. PubMed ID: 19797849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biosecurity Measures in Clinical Practice.
    Byers CG
    Vet Clin North Am Small Anim Pract; 2020 Nov; 50(6):1277-1287. PubMed ID: 32829951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. European perspective of 2-person rule for biosafety level 4 laboratories.
    Ippolito G; Nisii C; Di Caro A; Brown D; Gopal R; Hewson R; Lloyd G; Gunther S; Eickmann M; Mirazimi A; Koivula T; Georges Courbot MC; Raoul H; Capobianchi MR
    Emerg Infect Dis; 2009 Nov; 15(11):1858. PubMed ID: 19891889
    [No Abstract]   [Full Text] [Related]  

  • 39. Certification & validation of biosafety level-2 & biosafety level-3 laboratories in Indian settings & common issues.
    Mourya DT; Yadav PD; Khare A; Khan AH
    Indian J Med Res; 2017 Oct; 146(4):459-467. PubMed ID: 29434059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strengthening Biorisk Management Capacities in Burkina Faso: Contribution of the Global Health Security Agenda.
    Dama E; Orelle A; Nikiema A; Mandingar PD; Naby A; Bationo GB; Kéita MS; Pierson A; Sawadogo C; Koné RG
    Health Secur; 2022; 20(6):479-487. PubMed ID: 36399610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.